HACE1 and ductal breast carcinoma in situ: To determine whether HACE1 loss increases invasiveness (a critical element of the transition from DCIS to invasive breast cancer), HACE1-depleted MCF12A cells were plated in the upper portion of a modified Boyden chamber coated with Matrigel.